Consultancy Circle

Artificial Intelligence, Investing, Commerce and the Future of Work

Day: July 7, 2025

  • AI-Designed Drugs: Isomorphic Labs Initiates Clinical Trials

    In a milestone moment that may reshape the future of pharmaceuticals, Isomorphic Labs, a drug discovery company launched by DeepMind, has taken a leap from theoretical biology to clinical application. As of early 2025, the company announced it is initiating Phase 1 clinical trials for its first artificial intelligence (AI)-designed drug candidates. This marks a…